Global Iloprost Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 106.17 Million |
Market Size (Forecast Year) |
USD 212.23 Million |
CAGR |
|
Major Markets Players |
|
>全球伊洛前列素市场,按药物类别(多环芳烃 (PAH)、前列环素类似物、其他)、人口统计(成人、老年人)、应用(肺动脉高压、系统性硬化症、其他)、剂型(溶液、其他)、给药途径(静脉、吸入)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房)划分 - 行业趋势和预测到 2030 年。
伊洛前列素市场分析和规模
伊洛前列素是一种用于治疗肺动脉高压 (PAH) 的药物。对于 PAH 患者,伊洛前列素可帮助他们增加运动量并减缓症状进展。伊洛前列素属于血管扩张剂类药物。它的作用是放松全身(包括肺部)的血管。它是一种前列环素 PGI2 类似物,可扩张体动脉和肺动脉的血管床。这种药物以口服吸入溶液的形式提供。白天,通常吸入六至九次。该药物的商品名为 ventavis。这种药物的副作用包括潮红、视力模糊、咳嗽、头痛、恶心、呕吐、下颌肌肉紧绷、喘息和呼吸困难等。
Data Bridge Market Research 分析称,2022 年全球伊洛前列素市场规模为 1.0617 亿美元,到 2030 年将飙升至 2.1223 亿美元,预计在 2023-2030 年预测期内复合年增长率为 11.50%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021 (可定制为 2015-2020) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
药物类别(多环芳烃 (PAH)、前列环素类似物、其他)、人口统计(成人、老年人)、应用(肺动脉高压、系统性硬化症、其他)、剂型(溶液、其他)、给药途径(静脉、吸入)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房) |
覆盖国家 |
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa |
Market Players Covered |
Bayer AG (Germany), Vectura Group plc (U.K.), VisionGate, Inc. (U.S.), Janssen Global Services, LLC (U.S.), Transo-Pharm Handels-GmbH (Germany), LGM Pharma (U.S.), Newchem (India), and YONSUNG Fine Chemicals Co., Ltd. (South Korea) |
Market Opportunities |
|
Market Definition
Iloprost, in the industry of pharmaceuticals, is a drug belonging to the anticonvulsant class of medications. It was initially developed to treat epileptic seizures, specifically partial seizures. Over time, its use has expanded to include the management of neuropathic pain and certain types of chronic pain. Iloprost functions by affecting the nerves and chemicals in the body that are involved in causing seizures and various types of pain.
Global Iloprost Market Dynamics
Drivers
- Growing Prevalence of Neuropathic Pain Disorders
The rising incidence of neuropathic pain disorders globally is a significant driver for the iloprost market. Neuropathic pain, often associated with conditions like diabetic neuropathy, post-herpetic neuralgia, and trigeminal neuralgia, necessitates effective pain management. Iloprost has proven efficacy in managing neuropathic pain, driving its demand and adoption.
- Expanding Applications and Off-Label Usage
Iloprost's versatility in treating various medical conditions beyond its initial intended use, such as anxiety disorders, migraines, and restless legs syndrome, contributes to market growth. Physicians and healthcare practitioners increasingly prescribe iloprost off-label for these conditions, broadening its market reach and fueling demand.
Opportunity
- Rising Awareness and Education Initiatives
There is a substantial opportunity for market growth through increased awareness and educational initiatives regarding iloprost's benefits, optimal usage, and potential side effects. Educating healthcare professionals, patients, and caregivers about the appropriate use of iloprost, its efficacy in managing various conditions, and safety precautions can enhance its acceptance and adoption. This educational approach can not only expand the market but also foster responsible usage, which is crucial in ensuring positive outcomes and mitigating potential risks.
Restraints/Challenges
- Concerns Regarding Abuse and Dependency
One significant restraint for the iloprost market is the rising concern regarding its potential for abuse and dependency. Reports of misuse and addiction, particularly when combined with other substances like opioids, have raised regulatory scrutiny and led to tighter control and monitoring of iloprost prescriptions. This has the potential to limit its usage and impact the overall market growth.
This iloprost market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the iloprost market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Recent Development
- In September 2023, Pfizer Inc. and BioNTech SE announced that they received approval from the U.S. Food and Drug Administration (FDA) for their supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation). This approval covers individuals aged 12 and above, and it includes emergency use authorization for children aged 6 months to 11 years, specifically for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The current vaccine season's recommendation is for a single dose for most individuals aged 5 and older. However, children under 5 years old may qualify for additional doses of this season's vaccine if they have not already completed a three-dose series with earlier formulations of a COVID-19 vaccine
Global Iloprost Market Scope
全球伊洛前列素市场根据产品类型、应用、给药途径、购买方式和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。
产品类型
- 胶囊
- 药片
应用
- 癫痫
- 神经性疼痛
- 不安腿综合症
给药途径
- 口服
- 肠外
- 静脉
购买方式
- 处方
- 零售
- 在柜台
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
全球伊洛前列素市场区域分析/见解
对伊洛前列素市场进行了分析,并按国家、产品类型、应用、给药途径、购买方式和分销渠道提供了市场规模洞察和趋势。
全球伊洛前列素市场报告涵盖的国家包括美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区。
由于治疗产品批准数量的激增以及政府和制药组织为在该地区传播有关该疾病的认识而采取的举措的增加,北美预计将在伊洛前列素市场中占据主导地位并实现最高的增长率。
由于亚太地区急性淋巴细胞/淋巴细胞白血病 (ALL) 患病率上升,亚太地区是伊洛前列素市场预计增长的地区。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和伊洛前列素市场份额分析
伊洛前列素市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对伊洛前列素市场的关注有关。
伊洛前列素市场的一些主要参与者包括:
- 拜耳公司(德国)
- Vectura Group plc (英国)
- VisionGate, Inc.(美国)
- Janssen Global Services, LLC(美国)
- Transo-Pharm Handels-GmbH(德国)
- LGM Pharma(美国)
- Newchem(印度)
- YONSUNG精细化工有限公司(韩国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.